Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016:36:98-103.

The Treatment and Outcomes of Extraskeletal Osteosarcoma: Institutional Experience and Review of The Literature

Lukas M Nystrom  1 , Nickolas B Reimer  1 , John D Reith  1 , Mark T Scarborough  1 , C Parker Gibbs Jr  1
Affiliations
Review

The Treatment and Outcomes of Extraskeletal Osteosarcoma: Institutional Experience and Review of The Literature

Lukas M Nystrom et al. Iowa Orthop J. 2016.

Abstract

Background: Extraskeletal osteosarcoma is a rare tumor with a poor prognosis. The purpose of this study is to examine the oncologic outcomes of this disease as they relate to surgical treatment and use of adjuvant therapies.

Methods: We retrospectively analyzed all patients treated at our institution for high-grade extraskeletal osteosarcoma of the limb or chest wall. We recorded demographic data, presenting stage, surgical margin, use of adjuvant chemotherapy or radiation, incidence of local recurrence, metastases, and death. Overall and event-free survival were calculated using Kaplan-Meier survival methods.

Results: There were 12 patients treated with primary wide resection or re-excision of a previously operated tumor bed. Four patients presented with metastases. Seven patients received chemotherapy and four patients received radiation therapy. There were two local recurrences, six patients developed new metastases, and nine patients died. There was no difference in overall survival in patients who received chemotherapy. There was, however, a trend towards increased length of survival in patients who received chemotherapy compared to those who did not (16.4 months vs. 9.3 months, p=0.16).

Conclusions: Despite no difference in overall survival, patients treated with adjuvant chemotherapy have a trend towards increased length of survival. We suggest that extraskeletal osteosarcoma be treated with standard osteosarcoma chemotherapy regimens in addition to wide resection.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(a) Plain radiographic image demonstrating an ossific mass in the region of the right hip. (b) Axial T1 post-contrast MRI demonstrating the mass arising from the right gluteal musculature with a thin peripheral rim of enhancement. (c) Positron emission tomography scan demonstrating the mass with very high standardized uptake value. (d) Hematoxylin and eosin slide demonstrating immature osteoid formation by malignant appearing spindle cells.
Figure 2.
Figure 2.
Kaplan-Meier survival plot of overall survival (OS) for the twelve patients in this series.
Figure 3.
Figure 3.
Kaplan-Meier survival plot of OS in patients who received chemotherapy compared to those who did not.
Figure 4.
Figure 4.
kaplan-meier analysis of event-free survival (efs) for the entire patient cohort.
See this image and copyright information in PMC

References

    1. Wurlitzer F, Ayala L, Romsdahl M. Extraosseous osteogenic sarcoma. Arch Surg. 1972;105(5):691–5. - PubMed
    1. Alpert LI, Abaci IF, Werthamer S. Radiationinduced extraskeletal osteosarcoma. Cancer. 1973;31(6):1359–63. - PubMed
    1. Sordillo PP, Hajdu SI, Magill GB, Golbey RB. Extraosseous osteogenic sarcoma. Cancer. 1983;51(4):727–34. A review of 48 patients. - PubMed
    1. Chung EB, Enzinger FM. Extraskeletal osteosarcoma. Cancer. 1987;60(5):1132–42. - PubMed
    1. Bane BL, Evans HL, Ro JY, Carrasco CH, Grignon DJ, Benjamin RS, Ayala AG. Extraskeletal Osteosarcoma: A Clinicopathologic Review of 26 Cases. Cancer. 1990;66(12):2762–70. - PubMed

MeSH terms

Substances

LinkOut - more resources